Search research articles
Contact Us
Filters
Showing results (41-50 of 131) with videos related to
Page
of 14
Sort By:
Trends in Genetics : TIG
|
August 14, 2012
IsomiRs--the overlooked repertoire in the dynamic microRNAome
Corine T Neilsen, Gregory J Goodall, Cameron P Bracken
Nature Reviews. Genetics
|
November 8, 2016
A network-biology perspective of microRNA function and dysfunction in cancer
Cameron P Bracken, Hamish S Scott, Gregory J Goodall
Cancer Research
|
June 13, 2015
Network-Based Approaches to Understand the Roles of miR-200 and Other microRNAs in Cancer
Cameron P Bracken, Yeesim Khew-Goodall, Gregory J Goodall
FEBS Letters
|
October 20, 1986
Spermine antagonises the effects of dexamethasone, glucagon and cyclic AMP in increasing the activity of phosphatidate phosphohydrolase in isolated rat hepatocytes
R A Pittner, P Bracken, R Fears, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
December 1, 1996
Prevalence of antibodies to hepatitis C and herpes simplex virus type 1 is not increased in children with liver kidney microsomal type 1 autoimmune hepatitis
G V Gregorio, P Bracken, G Mieli-Vergani, et al.
FEBS Letters
|
June 23, 1986
Insulin antagonises the growth hormone-mediated increase in the activity of phosphatidate phosphohydrolase in isolated rat hepatocytes
R A Pittner, P Bracken, R Fears, et al.
Clinical Science (London, England : 1979)
|
March 1, 1985
Amyloid 'degrading factor activity': a non-specific calcium-mediated effect
D L Scott, P Bracken, P A Bacon, et al.
Infection and Immunity
|
March 18, 2000
Antibodies to tyvelose exhibit multiple modes of interference with the epithelial niche of Trichinella spiralis
C S McVay, P Bracken, L F Gagliardo, et al.
Oncogene
|
January 30, 2007
Regulation of ATR-dependent pathways by the FHA domain containing protein SNIP1
K C Roche, S Rocha, C P Bracken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1994
Results of a clinical trial in humans with refractory cancer of the intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl, in combination with various single antineoplastic agents
L J Brandes, K J Simons, S P Bracken, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 131) with videos related to
Sort By:
Page
of 14
Trends in Genetics : TIG
|
August 14, 2012
IsomiRs--the overlooked repertoire in the dynamic microRNAome
Corine T Neilsen, Gregory J Goodall, Cameron P Bracken
Nature Reviews. Genetics
|
November 8, 2016
A network-biology perspective of microRNA function and dysfunction in cancer
Cameron P Bracken, Hamish S Scott, Gregory J Goodall
Cancer Research
|
June 13, 2015
Network-Based Approaches to Understand the Roles of miR-200 and Other microRNAs in Cancer
Cameron P Bracken, Yeesim Khew-Goodall, Gregory J Goodall
FEBS Letters
|
October 20, 1986
Spermine antagonises the effects of dexamethasone, glucagon and cyclic AMP in increasing the activity of phosphatidate phosphohydrolase in isolated rat hepatocytes
R A Pittner, P Bracken, R Fears, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
December 1, 1996
Prevalence of antibodies to hepatitis C and herpes simplex virus type 1 is not increased in children with liver kidney microsomal type 1 autoimmune hepatitis
G V Gregorio, P Bracken, G Mieli-Vergani, et al.
FEBS Letters
|
June 23, 1986
Insulin antagonises the growth hormone-mediated increase in the activity of phosphatidate phosphohydrolase in isolated rat hepatocytes
R A Pittner, P Bracken, R Fears, et al.
Clinical Science (London, England : 1979)
|
March 1, 1985
Amyloid 'degrading factor activity': a non-specific calcium-mediated effect
D L Scott, P Bracken, P A Bacon, et al.
Infection and Immunity
|
March 18, 2000
Antibodies to tyvelose exhibit multiple modes of interference with the epithelial niche of Trichinella spiralis
C S McVay, P Bracken, L F Gagliardo, et al.
Oncogene
|
January 30, 2007
Regulation of ATR-dependent pathways by the FHA domain containing protein SNIP1
K C Roche, S Rocha, C P Bracken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1994
Results of a clinical trial in humans with refractory cancer of the intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl, in combination with various single antineoplastic agents
L J Brandes, K J Simons, S P Bracken, et al.
Page
of 14